PL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. PL is pulling back pre-market (~25.68, -2.43%) with short-term momentum weakening (MACD histogram negative and expanding) while the stock is already trading above most recent Wall Street price targets (generally $16–$22). With upside looking more dependent on continued headline wins than on near-term technical strength, the risk/reward at this level is not attractive for an immediate entry.
Trend/structure: Medium-term trend remains bullish on moving averages (SMA_5 > SMA_20 > SMA_200), suggesting the broader uptrend is still intact. Momentum: MACD histogram is -0.237 and negatively expanding, indicating the current pullback is strengthening rather than stabilizing. RSI: RSI_6 ~49 (neutral), so there’s no clear oversold bounce signal yet. Key levels: Pivot 27.763 is overhead resistance (bulls typically want to reclaim this). Immediate support is S1 25.56 (price is trading right on top of it pre-market); a break below opens risk toward S2 24.198. Resistance levels are R1 29.966 then R2 31.327. Pattern-based odds: Similar-pattern stats imply a modest bullish skew (60% chance) with ~0.71% next day, ~1.11% next week, ~5.57% next month—positive but not strong enough to outweigh weakening momentum at current price.
Intellectia Proprietary Trading Signals
Defense/sovereign demand tailwinds: News flow highlights defense optimism tied to Trump’s “Golden Dome” missile defense plan, which is benefiting defense-related names broadly.
Commercial traction: Planet Labs partnerships in Europe (Slovenia agreements) expand government use cases (agriculture, urban planning, disaster response).
Company execution headlines: Record Q3 FY2026 revenue ($81M) and a reported nine-figure Sweden military contract are strong catalysts that can continue to support sentiment.
Street target mismatch: The stock price (~mid-20s) is above most cited targets ($16–$22 range), creating a valuation/expectations headwind for incremental upside.
suggests the market is already paying up for upside/volatility, which can reduce the attractiveness of new entries at current prices.
Latest quarter: 2026/Q3 (Fiscal Q3 2026). Growth: Revenue rose to ~$81.25M, up ~32.62% YoY—strong top-line acceleration. Profitability trend: Net income was -$59.19M and EPS was -$0.19 (still meaningfully negative), indicating the company remains loss-making despite revenue growth. Margins: Gross margin fell to ~57.33%, down ~6.70% YoY, a notable deterioration that can pressure the path to sustained profitability.
Recent trend: Ratings/targets moved sharply upward after the fiscal Q3 beat and defense momentum. Multiple firms reiterated/issued Buy/Outperform and raised targets (Clear Street to $22; Needham to $22; Wedbush to $20; Citi initiated Buy at $19; Deutsche Bank/Northland raised to ~$17). Goldman and Morgan Stanley raised targets but stayed Neutral/Equal Weight. Wall Street pros: Strong defense & intelligence traction, AI-driven product differentiation, expanding multi-year programs, and improving EBITDA outlook. Wall Street cons: Some major banks remain neutral, and even bullish targets (mostly $19–$22) sit below the current trading range, implying limited upside if the stock is already pricing in much of the good news. Influential/political trading: No recent congress trading data available; hedge fund and insider trends are neutral with no notable recent activity.
